Literature DB >> 638014

Studies with a spontaneous mouse tumor. I. Growth in normal mice and response to Corynebacterium parvum.

M F Woodruff, V L Whitehead, G Speedy.   

Abstract

Growth of isogeneic transplants of a spontaneous murine adenocarcinoma, which is virtually devoid of tumour-specific transplantation antigens, is inhibited by i.v. injection of C. parvum 3 days after tumour inoculation, or by mixing a small dose of C. parvum with the tumour inoculum. Moreover, the therapeutic effect of cyclophosphamide, followed by i.v. or i.p. injection of C. parvum 5 days later, on established transplants of the same tumour is greater than that of cyclophosphamide alone. These findings are consistent with the hypothesis that in both situations (i.e. before the appearance of a palpable tumour and after reduction of an established tumour transplant with cyclophosphamide) the effect of C. parvum is largely due to activation of macrophages or macrophage precursors. They have the important practical implication that adjuvant therapy with C. parvum may be of value, even with tumours which are devoid of TSTA.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 638014      PMCID: PMC2009515          DOI: 10.1038/bjc.1978.53

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

Review 1.  Tumor inhibitory properties of anaerobic Corynebacteria.

Authors:  M F Woodruff
Journal:  Transplant Proc       Date:  1975-06       Impact factor: 1.066

2.  Mechanism of Inhibition of immunization with irradiated tumour cells by a large dose of Corynebacterium parvum.

Authors:  M Woodruff; V L Whitehead
Journal:  Proc R Soc Lond B Biol Sci       Date:  1977-07-20

3.  THE EFFECT OF X-RAY ON THE ANTIGENICITY OF DONOR CELLS IN TRANSPLANTATION IMMUNITY.

Authors:  C F MCKHANN
Journal:  J Immunol       Date:  1964-05       Impact factor: 5.422

4.  Modification of the effect of C. parvum on macrophage activity and tumour growth by X-irradiation.

Authors:  M F Woodruff; A Ghaffar; V L Whitehead
Journal:  Int J Cancer       Date:  1976-05-15       Impact factor: 7.396

5.  Effect of Corynebacterium parvum on tumor growth in normal and athymic (nude) mice.

Authors:  M F Woodruff; N L Warner
Journal:  J Natl Cancer Inst       Date:  1977-01       Impact factor: 13.506

6.  Effect of local injection of Corynebacterium parvum on the growth of a murine fibrosarcoma.

Authors:  M F Woodruff; N Dunbar
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

7.  A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin.

Authors:  H B Hewitt; E R Blake; A S Walder
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

8.  Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts.

Authors:  M F Woodruff; J L Boak
Journal:  Br J Cancer       Date:  1966-06       Impact factor: 7.640

9.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

  9 in total
  4 in total

1.  Immunochemotherapy of breast cancer with Propionibacterium granulosum.

Authors:  K Roszkowski; B Nozdryn-Plotnicki; W Roszkowski; H L Ko; G Pulverer; J Jeljaszewicz
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

2.  Post operative stimulation of cell mediated immunity.

Authors:  J A Smith; W S Hendry; J L Duncan; J N Norman
Journal:  Klin Wochenschr       Date:  1985-10-01

3.  The choice of experimental tumour systems.

Authors:  O C Scott
Journal:  Br J Cancer Suppl       Date:  1980-04

4.  Further studies on antitumour responses induced by short-term pretreatment with syngeneic tumour cells.

Authors:  K James; I Milne; J Merriman; W H McBride
Journal:  Br J Cancer       Date:  1979-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.